Abstract
In high-income countries, it would be inconceivable to treat a tumour when its pathology is unknown. However, this can be the case among patients in sub-Saharan Africa. The absence of pathologists and the resultant delays in reporting contribute to patients being treated before the nature of the lesion is known. This is compounded by the frequent absence of auxiliary tests to better define tumour characteristics.